This new technology is hailed by its inventor as a life-saving bandage that can succeed in situations where conventional treatment procedures may not be able to stop fatal bleeding.
A new Israeli-developed bandage is designed to save lives in the event of severe bleeding, in which case conventional treatment procedures may not be able to stop the fatal bleeding.
According to Yuval Yaskil, owner and CEO of developer Core Scientific Creations (CSC), the bandage, called WoundClot, not only stops severe bleeding within a few minutes-without putting pressure on the wound-but also strengthens the blood. The natural coagulation process.
Yaskil told Reuters from his office in the Israeli city of Kfar Saba that severe, uncontrolled bloodshed was the number one cause of death on the battlefield. Although the traditional treatment of this type of bleeding involves applying pressure to the wound to stop it from bleeding and taking the patient to the hospital, Yaskil said that in some cases, such as a neck stab or head trauma, pressure does not work.
Yaskil said: "These products allow us to treat very severe bleeding on-site, with minimal training and minimal interference with conventional medical treatment or protocols used today."
Yaskil explained that simply preventing blood from leaving the patient’s body is not enough, because sometimes it takes several hours for the patient to reach the hospital. He said this is why WoundClot uses a chemical process to stop bleeding, enhance the natural clotting process, while maintaining its own stability for 24 hours.
"Our product is unique because it is the only non-pressurized application on the market for severe bleeding and is bioabsorbable. Because this is a contradiction: bioabsorbable means you want the product to decompose, but And controlling severe bleeding means that you must have a very stable membrane. This is basically a technique, or a patent that we developed," he said.
The idea behind WoundClot Science is Dr. Shani Eliyahu Gross, Vice President and Chief Technology Officer of CSC. Dr. Eliyahu Gross lifted up a dry wound clot-it looks like any other bandage-and soaked it in water, explaining that its unique chemical structure allows it to absorb large amounts of liquid without breaking down.
"When it is exposed to liquid, this product starts to absorb a lot of blood and then turns into a gel state," she said, adding that the more blood the bandage absorbs, the faster the clotting process proceeds.
"This special molecular structure actually combines the entire physical structure with the blood absorbed by the product and keeps the blood active, helping the wound to clot and stop bleeding," she said.
A video clip of a trial operation recorded and edited by CSC shows how a 10 x 10 cm WoundClot strip can stop bleeding from a liver wound in less than three minutes.
Yaskil said that CSC is providing WoundClot to the Israeli police force and army and selling it to hospitals, where treating bleeding requires precious time and expensive products in the emergency room or operating room.
The cost of WoundClot ranges from less than US$10 per bandage to the cost of larger surgical products as high as US$100. Although this price range is in the high-end range of the market, Yaskil said that this kind of bandage can replace other products or procedures that cost thousands of dollars.
"We are replacing very, very expensive products because... our products do not have any active ingredients. They only work on a physical, biological, and physiological level. This is what it does. But it does It is so effective that in many cases, we will replace products with active ingredients that promote blood clotting."